This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (27)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Frederick P. Li, MD; Roger R. Connelly, MSc; Max Myers, PhD

JAMA. 1982;247(6):825-826.

Abstract
Mortality rates of testis cancer among US whites declined 34% between 1973 and 1978. The change is attributable to improved therapy for patients with disseminated testis cancer other than seminoma. Thirty-month survival rates among these patients increased from 22% in 1973 to 1976 to 56% in 1977 to 1979 in nine geographic areas monitored by the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.

(JAMA 1982;247:825-826)

Author Affiliations
From the Clinical Epidemiology (Dr Li) and Biometry (Mr Connelly and Dr Myers) Branches, National Cancer Institute, Bethesda, Md.

Footnotes
Reprint requests to Landow A521, National Cancer Institute, Bethesda, MD 20205 (Dr Li).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?